From: Tumor mica status predicts the efficacy of immunotherapy with cytokine-induced killer cells for patients with gastric cancer
Variable
DFS
OS
P value
Hazard ratio
95%Ci
Stage
0.001
1.915
1.270-2.886
0.010
1.713
1.138-2.577
MICA
0.035
1.578
1.033-2.409
0.040
1.557
1.020-2.376